Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Special Offers and Promotions


Microscopy | Image Analysis



View Channel

Separation Science



View Channel

Coronavirus (COVID-19)



View Channel

Research & Case Studies



View Channel

Brochures & Literature



View Channel


Conferences | Events

Thermo Fisher Scientific Continues Investment in Global Manufacture of Bioprocessing Products

cellfactoriesThermo Fisher Scientific Inc., the world leader in serving science, has extended its state-of-the-art manufacturing capability in Shanghai, China, for the production of Thermo Scientific Nunc Cell Factory single-use, certified-sterile bioprocessing systems. This announcement forms part of a continuing strategy of global investment in the regional production of its high-quality bioprocessing products, to support the local bioproduction of vaccines, cell and protein therapeutics. The increased capacity builds on Thermo Fisher Scientific's position as the leading developer of single-use products for bioproduction, while meeting the demands of the European, North American and Asia-Pacific bioproduction markets.  

The Shanghai facility complements the NuncTM Cell Factory production sites in Rochester, New York, and Roskilde, Denmark. Commenting on the new investment, Chuck Kummeth, president of the laboratory consumables division of Thermo Fisher Scientific said, "The Rochester, Roskilde and Shanghai sites are designed to meet local and international demands both now and in the future, and will facilitate the effective streamlining and continuity of supply for our growing customer base. Our aim is to provide regional biopharma production sites with the fastest and most efficient delivery of cell culture consumables, and to enable us to do this, we are currently investing heavily in the APAC region in particular."  

Stringent quality control procedures are in place across all of the global sites to guarantee the consistent delivery of highest-quality products. Referring to Thermo Fisher Scientific's drive for market-leading quality, Kummeth said, "Product quality is paramount, and the provision of cell culture platforms and containment systems that are specifically developed to facilitate easy scale-up and commercialization of bioproduction processes, have been key to our success so far."  

Thermo Scientifics bioprocessing products portfolio is complemented by media supplements, process liquids and cell culture sera, and the extended production facilities in Shanghai follows a recently opened site in Beijing dedicated to the hydration of cell culture media, and a joint venture in Lanzhou, China, for the collection, processing and selling of serum into local markets. Further multi-million dollar investments have been made at production sites based in Cramlington, UK and Logan, Utah.   

For more information on the broad portfolio of bioprocessing systems and solutions, please visit

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month...

Our Top 10 most popular articles this month


Today's Picks...




Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners